FDA Approval: ZYVOX (LINEZOLID) — Type 1 - New Molecular Entity
Policy FDA-NDA021130 · Infectious Disease
ZYVOX (Linezolid) is an oral antibacterial drug that falls under Medicare Part D for billing. Since it is not an injectable, a J-code assignment is not applicable. No pass-through payment or ASP+6% wi